Epistaxis, the leading sign of HHT and the most frequent clinical manifestation, occurs earlier in HHT1 and shows an increasing trend in HHT2 subjects [ 1 , 2 ].
← all excerpts
Impact of SARS-CoV-2 infection in patients with hereditary hemorrhagic telangiectasia: epidemiological and clinical data from the comprehensive Italian retrospective multicenter study.
1
—
—